Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Balance Sheets

v3.22.2.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 68,620 $ 104,484
Short-term investments 27,470  
Prepaid expenses and other current assets 4,141 3,569
Accounts receivable, net 2,493 861
Inventory, net 786 463
Restricted cash 55 0
Total current assets 103,565 109,377
Other assets 5,076 6,235
Deferred offering costs 73 150
Restricted cash 163 218
Intangible assets, net 770 1,056
Operating lease right-of-use asset (See Note 8) 2,646 2,801
Total assets 112,293 119,837
Current liabilities:    
Accounts payable 7,419 7,848
Accrued expenses 5,856 5,698
Other liabilities, current portion (See Note 7) 720 0
Operating lease liability, current portion (See Note 8) 269 70
Total current liabilities 14,264 13,616
Other liabilities (See Note 7) 4,898 3,345
Warrant liabilities 27,730 18,062
Convertible debt and derivative liability (See Note 7) 11,032 11,607
Loan payable 34,162 28,745
Operating lease liability (See Note 7) 2,998 3,204
Total liabilities 95,084 78,579
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, authorized 5,000,000 shares as of September 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value, 150,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 32,656,242 and 28,705,334 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 36 32
Additional paid-in capital 425,032 400,705
Accumulated deficit (407,859) (359,479)
Total stockholders’ equity 17,209 41,258
Total liabilities and stockholders’ equity $ 112,293 $ 119,837